— U.S. OTC Listing Platform and Antibiotic-Free Agriculture Assets Explore
Cross-Shareholding and Industrial-Capital Synergy —
DALLAS / SHENZHEN, October 11, 2026 — China Health Management Corp. (OTC: CNHC) and
Sante Technology Holdings Inc. (OTC: SNTE) today announced the signing of a Strategic
Cooperation Agreement to collaborate on bio-agriculture industrialization, cross-border
capital-market support, and future reciprocal equity investment.
Pursuant to the Agreement, CNHC will provide Sante Technology's operating affiliates —
Shenzhen Duogao Biotechnology Co., Ltd. and Shijiazhuang Guangwei Agriculture and Animal
Husbandry Co., Ltd. — with overseas listing-platform positioning, investor-relations
coordination, and international brand building for bio-feed and premium meat products.
CNHC will also explore connecting Sante Technology's agricultural bio-economy assets with
U.S. OTC capital markets and global protein-food distribution channels.
Sante Technology brings a comprehensive technology system spanning breeding, bio-feed R&D,
and livestock disease control, anchored by a "full-cycle antibiotic-free farming system"
covering no antibiotics at source, disease resistance through animal constitution,
antibiotic reduction during production, and antibiotic-free terminal products. Its North
China base (Guangwei Agriculture) operates at the 300,000-ton annual bio-feed capacity
level, creating North-South synergy with Duogao Biotech. Sante Technology has also
developed motion-nutrition peptides and targeted nutritional-regulation premium meat
products with strong commercialization potential.
Beyond operational collaboration, the parties agreed to explore a cross-shareholding
arrangement at an appropriate future date. Subject to U.S. securities laws and OTC Market
rules, upon Sante Technology's applicable entities achieving agreed revenue/net-profit
thresholds for two consecutive fiscal years, and following respective approvals and receipt
of U.S. securities-counsel compliance opinions, the parties will discuss a reciprocal
common-stock exchange. The share-swap window remains open for 24 months from the
Agreement's effective date.
CNHC CEO stated: "Sante Technology's antibiotic-free farming and bio-feed assets are
precisely the kind of entity-backed agricultural technologies that a U.S. OTC platform
can help scale internationally."
SNTE CEO stated: "CNHC's listing platform and cross-border capabilities will accelerate
our commercialization of antibiotic-free farming technologies and premium protein products."
The Agreement is non-binding and framework in nature. Specific projects will be governed
by separate definitive contracts.
About CNHC:
China Health Management Corp. is a Nevada-incorporated company quoted on OTC Markets,
repositioning from legacy healthcare-management narratives toward a platform combining
health, agricultural bio-economy, and cross-border industrial assets.
About SNTE:
Sante Technology Holdings Inc. is a U.S. OTC-quoted company. Through its acquisitions of
Shenzhen Duogao Biotechnology Co., Ltd. and Shijiazhuang Guangwei Agriculture and Animal
Husbandry Co., Ltd., the Company has established a deep presence in China's bio-feed,
antibiotic-free farming, and premium meat sectors. It has built an integrated industry
chain spanning breeding, feed R&D, and livestock disease control, and maintains a leading
domestic position in mutton-sheep fattening, layer-hen farming, plant-derived feed
formulation, antibiotic-free fermented feed strains, and livestock disease prevention.
Forward-Looking Statements / Safe Harbor:
This press release contains forward-looking statements within the meaning of Section 27A
of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.
Actual results may differ materially due to, among other things, the non-binding nature
of the framework agreement, failure to execute definitive contracts, inability to meet
agreed financial thresholds, regulatory constraints, financing conditions, approval
requirements, and general market or operating risks. Readers should not place undue
reliance on forward-looking statements, which speak only as of the date hereof. The
companies assume no obligation to update such statements except as required by law.
This press release does not constitute an offer to sell or a solicitation of an offer to
buy any securities.
Cross-Shareholding and Industrial-Capital Synergy —
DALLAS / SHENZHEN, October 11, 2026 — China Health Management Corp. (OTC: CNHC) and
Sante Technology Holdings Inc. (OTC: SNTE) today announced the signing of a Strategic
Cooperation Agreement to collaborate on bio-agriculture industrialization, cross-border
capital-market support, and future reciprocal equity investment.
Pursuant to the Agreement, CNHC will provide Sante Technology's operating affiliates —
Shenzhen Duogao Biotechnology Co., Ltd. and Shijiazhuang Guangwei Agriculture and Animal
Husbandry Co., Ltd. — with overseas listing-platform positioning, investor-relations
coordination, and international brand building for bio-feed and premium meat products.
CNHC will also explore connecting Sante Technology's agricultural bio-economy assets with
U.S. OTC capital markets and global protein-food distribution channels.
Sante Technology brings a comprehensive technology system spanning breeding, bio-feed R&D,
and livestock disease control, anchored by a "full-cycle antibiotic-free farming system"
covering no antibiotics at source, disease resistance through animal constitution,
antibiotic reduction during production, and antibiotic-free terminal products. Its North
China base (Guangwei Agriculture) operates at the 300,000-ton annual bio-feed capacity
level, creating North-South synergy with Duogao Biotech. Sante Technology has also
developed motion-nutrition peptides and targeted nutritional-regulation premium meat
products with strong commercialization potential.
Beyond operational collaboration, the parties agreed to explore a cross-shareholding
arrangement at an appropriate future date. Subject to U.S. securities laws and OTC Market
rules, upon Sante Technology's applicable entities achieving agreed revenue/net-profit
thresholds for two consecutive fiscal years, and following respective approvals and receipt
of U.S. securities-counsel compliance opinions, the parties will discuss a reciprocal
common-stock exchange. The share-swap window remains open for 24 months from the
Agreement's effective date.
CNHC CEO stated: "Sante Technology's antibiotic-free farming and bio-feed assets are
precisely the kind of entity-backed agricultural technologies that a U.S. OTC platform
can help scale internationally."
SNTE CEO stated: "CNHC's listing platform and cross-border capabilities will accelerate
our commercialization of antibiotic-free farming technologies and premium protein products."
The Agreement is non-binding and framework in nature. Specific projects will be governed
by separate definitive contracts.
About CNHC:
China Health Management Corp. is a Nevada-incorporated company quoted on OTC Markets,
repositioning from legacy healthcare-management narratives toward a platform combining
health, agricultural bio-economy, and cross-border industrial assets.
About SNTE:
Sante Technology Holdings Inc. is a U.S. OTC-quoted company. Through its acquisitions of
Shenzhen Duogao Biotechnology Co., Ltd. and Shijiazhuang Guangwei Agriculture and Animal
Husbandry Co., Ltd., the Company has established a deep presence in China's bio-feed,
antibiotic-free farming, and premium meat sectors. It has built an integrated industry
chain spanning breeding, feed R&D, and livestock disease control, and maintains a leading
domestic position in mutton-sheep fattening, layer-hen farming, plant-derived feed
formulation, antibiotic-free fermented feed strains, and livestock disease prevention.
Forward-Looking Statements / Safe Harbor:
This press release contains forward-looking statements within the meaning of Section 27A
of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.
Actual results may differ materially due to, among other things, the non-binding nature
of the framework agreement, failure to execute definitive contracts, inability to meet
agreed financial thresholds, regulatory constraints, financing conditions, approval
requirements, and general market or operating risks. Readers should not place undue
reliance on forward-looking statements, which speak only as of the date hereof. The
companies assume no obligation to update such statements except as required by law.
This press release does not constitute an offer to sell or a solicitation of an offer to
buy any securities.